Maria Antonella Zingaropoli

Pubblicazioni

Titolo Pubblicato in Anno
The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia JOURNAL OF NEUROIMMUNOLOGY 2020
Major reduction of NKT cells in patients with severe COVID-19 pneumonia CLINICAL IMMUNOLOGY 2020
Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis EUROPEAN RADIOLOGY 2020
Impact of ifn-free and ifn-based treatment on blood myeloid dendritic cell, monocyte, slan-dc, and activated t lymphocyte dynamics during hcv infection JOURNAL OF IMMUNOLOGY RESEARCH 2020
Dynamic changes of mmp-9 plasma levels correlate with jvc reactivation and immune activation in natalizumab-treated multiple sclerosis patients SCIENTIFIC REPORTS 2019
Reactivation of hepatitis B virus with immune-escape mutations after ocrelizumab treatment for multiple sclerosis OPEN FORUM INFECTIOUS DISEASES 2019
Fecal microbial transplantation impact on gut microbiota composition and metabolome, microbial translocation and T-lymphocyte immune activation in recurrent clostridium difficile infection patients NEW MICROBIOLOGICA 2019
JC virus-DNA detection is associated with CD8 fffector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus BIOMED RESEARCH INTERNATIONAL 2018
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters IMMUNOBIOLOGY 2018
FECAL MICROBIOTA TRANSPLANTATION VIA ENEMA FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION MODULATES THE INFLAMMATORY HOST RESPONSE AND RESTORE INTESTINAL DYSBIOSIS DIGESTIVE AND LIVER DISEASE. SUPPLEMENT 2017
Natalizumab affects T-cell phenotype in multiple sclerosis: implications for JCV reactivation PLOS ONE 2016
Archetype and rearranged non-coding control regions (NCCR) in urothelial bladder carcinoma of immunocompetent individuals CANCER GENOMICS & PROTEOMICS 2016
Higher levels of osteoprotegerin and immune activation/immunosenescence markers are correlated with concomitant bone and endovascular damage in HIV-suppressed patients PLOS ONE 2016
Baseline myeloid and lymphoid activation markers can predict time to viral load reduction under 50 copies/mL and CD4 recovery, respectively, after highly active antiretroviral therapy initiation JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 2016
Cardiovascular risk in HIV-positive subjects: analyses of T-cell phenotype and CD49d expression JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 2016
HIV-associated progressive multifocal leukoencephalopathy. Current perspectives NEUROBEHAVIORAL HIV MEDICINE 2016
Human polyomavirus JC replication and non coding control region analysis in multiple sclerosis patients under natalizumab treatment JOURNAL OF NEUROVIROLOGY 2015
Modificazioni immunofenotipiche dei linfociti T in pazienti affetti da sclerosi multipla in trattamento con natalizumab: implicazioni per la riattivazione del JC virus XIV Congresso Nazionale SIMIT 2015

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma